NCT02989935Active, not recruitingPhase 4
RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD
Source: ClinicalTrials.gov · Last updated 18 Feb 2025
Brief summary (registry, in English)
This study examines the effect of the ultra long acting beta agonist/corticosteroid bronchodilator combination fluticasone furoate/vilanterol trifenatate, on respiratory muscles and ventilation in adults with severe bronchitis or emphysema (COPD).
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 1 Dec 2016
- Start date
- Apr 2016
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- University of Calgary
- Diseases
- COPD
- NCT number
- NCT02989935
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 30
- From Apr 2016 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- hypersensitivity to milk proteins
- angina or substantial cardiovascular risk
- significant non-respiratory system disease
Other
- hypersensitive to fluticasone furoate/vilanterol formulation
- exacerbation of COPD within the preceding 2 months
Who the study is looking for
- ambulatory, stable severe COPD (GOLD Class III-IV)
- on long acting bronchodilator therapy
- compliant with use of prescribed medications
- fit for minor surgical procedure including intravenous sedation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Of Calgary Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.